Advancing Neuroscience with Dave Rosa of NeuroOne
University Hospitals Completes Groundbreaking Ablation Procedure Using NeuroOne's OneRF System
NeuroOne submits FDA market application for OneRF Ablation System
NeuroOne submits RF ablation system for FDA 510(k) clearance
NeuroOne successfully completes feasibility study with OneRF ablation system
NeuroOne Completes Feasibility Study with OneRF Ablation System
NeuroOne Plans to Ask FDA to Clear RF Ablation System in New Year
NeuroOne completes feasibility study of OneRF ablation system
NeuroOne begins shipping 30-day sEEG electrodes to Zimmer Biomet
NeuroOne developing brain electrode to help patients with neurological diseases
NeuroOne Tried Again – And Succeeded
NeuroOne sEEG Electrode Approved for 30-Day Use
FDA grants 510(k) clearance for NeuroOne's Evo sEEG Electrode technology
FDA Clears NeuroOne Evo sEEG Device for Use Up to 30 Days
FDA clears NeuroOne's Evo sEEG electrode for 30-day use
FDA OKs NeuroOne's Evo sEEG for Under 30 Day Use
Special 510(k) submitted to FDA for Evo sEEG Electrode
How NeuroOne and Zimmer Biomet will partner on robotic brain surgery
Thin, Flexible Electrode May Reduce Hospitalizations and Surgeries
NeuroOne Re-submits Application For SEEG Electrode To Extend Duration Of Use
NeuroOne rallies on receiving $3.5M in accelerated milestone payment from Zimmer Biomet
NeuroOne may consider partnerships next year with FDA clearance, CEO says
NeuroOne: Thinner Is Better When It Comes To Brain Electrodes
NeuroOne announces first clinical case using Evo sEEG electrodes
Thin Film Electrodes for Neuro Applications: Interview with Dave Rosa, CEO of NeuroOne
NeuroOne Achieves Milestone for Thin Film Electrode Technology
Meet NeuroOne: Fly exclusive interview with CEO Dave Rosa
Neuroone touts longevity stimulation data for electrode film tech
NeuroOne's next-generation electrodes to treat neurological disorders
NeuroOne reports successful durability tests of thin-film electrodes
NeuroOne completes initial pre-clinical testing of its thin film electrode technology
NeuroOne appoints Vice President of Quality Control and Regulatory Affairs
Interview with NeuroOne CEO Dave Rosa
NeuroOne CEO Dave Rosa talks uplisting on Nasdaq, upcoming advancements
A Conversation with Dave Rosa, President and CEO of NeuroOne
FDA clears NeuroOne Medical Technologies' Evo sEEG electrode
NeuroOne successfully completes feasibility study of Evo ablation electrode
FDA clears NeuroOne's Evo sEEG electrode
FDA clears NeuroOne's Evo sEEG electrode
Epilepsy tech company NeuroOne starts trading on the Nasdaq
Thin film electrodes show potential for transforming neurosurgery
NeuroOne thin film electrode technology enables extended, minimally invasive device
NeuroOne developing electrode technology to treat neurological conditions